Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Myocardial inflammation in myocarditis: mechanisms and therapeutic targets.

Frontiers in cardiovascular medicine·2026
Same author

Reply to the letter: 'multimodality imaging in cardio-oncology: from detection to actionable management to the editor'.

European heart journal. Cardiovascular Imaging·2026
Same author

Management of Bleeding Disorder During Dual Antiplatelet Therapy.

JACC. Case reports·2026
Same author

Pathophysiology, prevention, and management of coronary microvascular obstruction.

European heart journal·2026
Same author

Percutaneous coronary intervention or conservative therapy for chronic total coronary occlusions (CTOs)? Evidence from the ISCHEMIA trial.

European heart journal supplements : journal of the European Society of Cardiology·2026
Same author

QRS Index as a Predictor of Response to Cardiac Resynchronization Therapy: A Systematic Review and Meta-Analysis.

Journal of clinical medicine·2026

Related Experiment Video

Updated: Jun 26, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Myocarditis Prognostic Score: A New Risk Assessment Tool.

Daniela Di Lisi1, Cristina Madaudo2, Francesca Macaione1

  • 1Division of Cardiology, University Hospital Paolo Giaccone, 90127 Palermo, Italy.

Journal of Cardiovascular Development and Disease
|June 25, 2026
PubMed
Summary
This summary is machine-generated.

A new prognostic score helps identify patients with myocarditis at high risk for cardiovascular outcomes. This score utilizes clinical data and cardiac magnetic resonance imaging to predict adverse events, aiding clinical decision-making.

Keywords:
cardiac magnetic resonancemyocarditisprognosisscore

Related Experiment Videos

Last Updated: Jun 26, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Inflammatory Diseases

Background:

  • Myocarditis is a myocardial inflammatory condition with varied causes and prognoses.
  • Identifying patients at high risk for adverse cardiovascular outcomes is crucial for effective management.

Purpose of the Study:

  • To develop a multiparametric prognostic score for myocarditis patients.
  • To identify individuals with a higher likelihood of experiencing cardiovascular events.

Main Methods:

  • A prospective study included 98 myocarditis patients (72 M, 26 F; median age 27).
  • Patients were categorized into complicated (CM) and uncomplicated (UM) groups.
  • Cardiac magnetic resonance (CMR) and clinical assessments were performed at baseline and 6 months; outcomes were tracked for 3 years.

Main Results:

  • Complicated myocarditis (31 patients) had significantly higher cardiovascular outcomes than uncomplicated (67 patients).
  • Predictive factors for adverse outcomes included reduced LVEF, impaired global longitudinal strain, septal LGE on CMR, persistent troponin elevation, and LGE progression.
  • A developed myocarditis prognostic score (≥ 5) demonstrated high sensitivity (100%) and specificity (87%) for predicting cardiovascular outcomes.

Conclusions:

  • The study confirms a higher incidence of cardiovascular outcomes in complicated myocarditis patients.
  • A novel prognostic score effectively identifies high-risk myocarditis patients, facilitating targeted interventions.